methane has been researched along with epirubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; He, H; Hong, H; Huang, J; Pham-Huy, C; Pierre, D; Tan, S | 1 |
| He, H; He, J; Li, LL; Lin, R; Qiu, LL | 1 |
| Cui, M; Ding, J; Gao, X; Jiang, S; Jin, X; Jin, Y; Li, N; Sun, X; Suo, N; Wang, M; Zhang, H; Zheng, J | 1 |
3 other study(ies) available for methane and epirubicin
| Article | Year |
|---|---|
Adsorption behavior of epirubicin hydrochloride on carboxylated carbon nanotubes.
Topics: Adsorption; Antibiotics, Antineoplastic; Drug Carriers; Drug Stability; Epirubicin; Hydrogen-Ion Concentration; Kinetics; Nanotubes, Carbon; Temperature | 2011 |
[Adsorption and release behavior of epirubicin hydrochloride on carboxylated single-walled carbon nanotubes].
Topics: Adsorption; Antibiotics, Antineoplastic; Carboxylic Acids; Drug Carriers; Epirubicin; Nanotubes, Carbon | 2013 |
Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer.
Topics: Administration, Intravesical; Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Epirubicin; Female; Humans; Ki-67 Antigen; Magnetics; Male; Nanotubes, Carbon; Rats; Urinary Bladder Neoplasms | 2019 |